Paradoxic effects of metformin on endothelial cells and angiogenesis
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Paradoxic effects of metformin on endothelial cells and angiogenesis
Authors
Keywords
-
Journal
CARCINOGENESIS
Volume 35, Issue 5, Pages 1055-1066
Publisher
Oxford University Press (OUP)
Online
2014-01-14
DOI
10.1093/carcin/bgu001
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metformin Suppresses Ovarian Cancer Growth and Metastasis with Enhancement of Cisplatin Cytotoxicity In Vivo
- (2015) Ramandeep Rattan et al. NEOPLASIA
- Association of metformin use with cancer incidence and mortality: A meta-analysis
- (2013) Pengpeng Zhang et al. Cancer Epidemiology
- Metformin targets c-MYC oncogene to prevent prostate cancer
- (2013) Tunde Akinyeke et al. CARCINOGENESIS
- Low Concentrations of Metformin Selectively Inhibit CD133+ Cell Proliferation in Pancreatic Cancer and Have Anticancer Action
- (2013) Shanmiao Gou et al. PLoS One
- Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth
- (2013) H. A. Hirsch et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inflammation during obesity is not all bad: evidence from animal and human studies
- (2012) Jianping Ye et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Effects of metformin in women with polycystic ovary syndrome treated with gonadotrophins forin vitrofertilisation and intracytoplasmic sperm injection cycles: a systematic review and meta-analysis of randomised controlled trials
- (2012) S Palomba et al. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
- Tumor growth inhibitory effect of ADAMTS1 is accompanied by the inhibition of tumor angiogenesis
- (2012) Masanari Obika et al. CANCER SCIENCE
- Metformin Prevents the Development of Chronic Heart Failure in the SHHF Rat Model
- (2012) A. Cittadini et al. DIABETES
- Cancer prevention by targeting angiogenesis
- (2012) Adriana Albini et al. Nature Reviews Clinical Oncology
- Metformin Accelerates the Growth of BRAF V600E -Driven Melanoma by Upregulating VEGF-A
- (2012) Matthew J. Martin et al. Cancer Discovery
- Metformin restores endothelial function in aorta of diabetic rats
- (2011) Cristina M Sena et al. BRITISH JOURNAL OF PHARMACOLOGY
- The White Adipose Tissue Used in Lipotransfer Procedures Is a Rich Reservoir of CD34+ Progenitors Able to Promote Cancer Progression
- (2011) I. Martin-Padura et al. CANCER RESEARCH
- Tumor angiogenesis: molecular pathways and therapeutic targets
- (2011) Sara M Weis et al. NATURE MEDICINE
- CXCL12 (SDF-1)/CXCR4 Pathway in Cancer
- (2010) B. A. Teicher et al. CLINICAL CANCER RESEARCH
- Metformin: Taking away the candy for cancer?
- (2010) Mathilde Jalving et al. EUROPEAN JOURNAL OF CANCER
- Circulating perivascular progenitors: A target of PDGFR inhibition
- (2010) Patrizia Mancuso et al. INTERNATIONAL JOURNAL OF CANCER
- AMP-activated Protein Kinase (AMPK) Negatively Regulates Nox4-dependent Activation of p53 and Epithelial Cell Apoptosis in Diabetes
- (2010) Assaad A. Eid et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CYP1B1 and endothelial nitric oxide synthase combine to sustain proangiogenic functions of endothelial cells under hyperoxic stress
- (2009) Yixin Tang et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Metformin inhibits inflammatory angiogenesis in a murine sponge model
- (2009) D.O. Xavier et al. BIOMEDICINE & PHARMACOTHERAPY
- Metformin decreases angiogenesis via NF-κB and Erk1/2/Erk5 pathways by increasing the antiangiogenic thrombospondin-1
- (2009) Bee K. Tan et al. CARDIOVASCULAR RESEARCH
- Expression of CYP1A1 and CYP1B1 in human endothelial cells: regulation by fluid shear stress
- (2009) Daniel E. Conway et al. CARDIOVASCULAR RESEARCH
- Angiogenesis in the New Zealand obese mouse model fed with high fat diet
- (2009) Adriana Balwierz et al. Lipids in Health and Disease
- CYP1B1 expression promotes the proangiogenic phenotype of endothelium through decreased intracellular oxidative stress and thrombospondin-2 expression
- (2008) Y. Tang et al. BLOOD
- Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERα negative MDA-MB-435 breast cancer model
- (2008) Sirwan M. Hadad et al. BREAST CANCER RESEARCH AND TREATMENT
- Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERα negative MDA-MB-435 breast cancer model
- (2008) Kathryn N. Phoenix et al. BREAST CANCER RESEARCH AND TREATMENT
- The effect of metformin treatment on VEGF and PAI-1 levels in obese type 2 diabetic patients
- (2008) Canan Ersoy et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes
- (2008) Søren S Lund et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Targeting cytochrome P450 CYP1B1 with a therapeutic cancer vaccine
- (2008) Thomas M Luby Expert Review of Vaccines
- Nutrition and the Prevention and Treatment of Cancer: Association of Cytochrome P450 CYP1B1 With the Role of Fruit and Fruit Extracts
- (2008) William R. Ware INTEGRATIVE CANCER THERAPIES
- Is NF-κB a good target for cancer therapy? Hopes and pitfalls
- (2008) Véronique Baud et al. NATURE REVIEWS DRUG DISCOVERY
- The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
- (2008) I Ben Sahra et al. ONCOGENE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search